Skip to main content

Pavblu News

Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting

FRIDAY, May 9, 2025 – The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of aflibercept than in clinical trials, according to...

FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea

August 23, 2024 – The U.S. Food and Drug Administration (FDA) has announced the approval of Pavblu (aflibercept-ayyh) 2 mg injection (single-dose prefilled syringe and single-dose vial) for i...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Macular Degeneration, Macular Edema, Diabetic Macular Edema

Pavblu patient information at Drugs.com